Abstract
Cell culture is a major foundation of biopharmaceutical development,
bioprocessing and manufacturing. As the biopharmaceutical market grows, so
should interest in the cell culture products market. Biopharmaceutical
products are developed from large, complex protein molecules, which require
equally complex manufacturing methods and an array of analytical techniques.
As growing cells for biopharmaceutical production is slow, expensive and
complicated, optimizing cell culture development is of paramount concern to
companies developing biopharmaceuticals.
This report, Cell Culture represents the second time that Kalorama has focused
on culture used in the research and production of biopharmaceuticals,
analyzing the world cell culture market and the major trends driving this
market in three specific segments:
- Media,
- Sera, and
- Reagents
In addition to a thorough discussion of the technologies and techniques
currently employed and emerging in the cell culture area, the Kalorama' s
exhaustive report provides specific information on:
- Market Size, growth, and forecasts of the segments through 2013
- Competitive Market Share by leading supplier as of 2008.
- Estimated Market Share by Region (North America, Europe, U.S.)
- Key Market Drivers and Restraints for suppliers, including discussions of
biopharmaceutical pipelines, biomedical R&D directions, and the future of
transgenic plant and animal production.
- Review of the various expression systems (Bacteria, Yeast, Insect, and
Mammal) and the biopharmaceutical product manufactured by these systems
- Discussion of the preferences in media types vying for dominance in the
market, including the following:
- ADCF - animal derived component free media
- CD - chemically defined media
- CSFM - complete serum free medium
- PF - protein free media
- SF - serum free media
- SFM - serum free medium
- Major Trends Impacting the Market stem cell research (including plans of
major companies)cell culture-based vaccine Production and generic
bipharmaceuticals
- Profiles of 27 Leading Suppliers and information about M&A activities in
recent years
The information for this report was gathered using both primary and secondary
research including comprehensive research of secondary sources such as company
literature, databases, investment reports, and medical and business journals.
Telephone interviews and email correspondence were the primary method of
gathering information. For the purpose of this study Kalorama Information
conducted interviews with key industry officials, consultants, and government
personnel. These sources were the primary basis in gathering information
specifically relating to revenue and market share data presented in this
report. Specific interviews with pharmaceutical company and cell culture
supply company representatives included marketing directors, division
managers, and product representatives.
| 
View Cart
